19254952_1|19254952|18287|#section_info|0:0|In beta-arrestin1 siRNA-transfected cells, ANG  stimulation evokes a kinetic pattern of ERK activation similar to control but  with significantly elevated levels of activation at the 2-min time point, |#main_body|GO:0070373|negative regulation of ERK1 and ERK2 cascade|#go_definition|IMP|GOA|Arrb1(25387)|#gene_synonym
0.74	19254952_249|19254952|43209|DISCUSSION|0:0|In the present study, ANG-mediated ERK activation in  beta-arrestin1 siRNA-transfected VSMCs was not enhanced compared with that  from control siRNA-transfected cells except at the 2-min time point, and  SII-mediated ERK activation was not changed in beta-arrestin1  siRNA-transfected cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	19254952_87|19254952|11914|EXPERIMENTAL PROCEDURES|0:0|p-ERK activation was expressed as percentage of the maximal  phosphorylated ERK obtained by ANG stimulation at 5 min.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19254952_130|19254952|20090|RESULTS|0:0|In contrast, pretreatment with PKC inhibitors (15 mum GFX and 10  mum Go6983) resulted in dramatic decreases (~75%) in ERK  activation at early time points (1 and 2 min) after ANG stimulation, but  little inhibition was observed at longer time points (10 and 20 min)  (Fig. 4).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19254952_6|19254952|220|abstract|0:0|Even though SII cannot induce  calcium influx (G protein activation) after receptor stimulation, it does  cause ERK activation, although less robustly than ANG.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19254952_132|19254952|20090|RESULTS|0:0|The  kinetic pattern of ERK activation in the presence of the PKC inhibitors GFX  and Go6983 in VSMCs (Fig. 4) is similar to that observed previously for ANG-stimulated,  beta-arrestin2-dependent ERK activation in HEK 293 cells expressing AT1R  (13).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19254952_214|19254952|33417|RESULTS|0:0|Signals at each condition were expressed as  percentage of the maximal p-ERK obtained at 5 min for ANG stimulation in  DMSO-treated VSMCs.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19254952_241|19254952|41245|DISCUSSION|0:0|By utilizing  beta-arrestin RNAi and PKC inhibitors, two pathways for ERK activation by  the AT1R expressed in HEK 293 cells have been distinguished previously; rapid  and transient G protein-dependent activation, which is sensitive to PKC  inhibitors versus slow and prolonged beta-arrestin2-dependent  activation, which is sensitive to beta-arrestin2 RNAi  (13).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19254952_242|19254952|41245|DISCUSSION|0:0|In VSMCs, pretreatment  with PKC inhibitors also specifically inhibits early activation of ERK  (1-2 min) but not that at later time points, indicating that early  activation of ERK requires G-protein-mediated second messenger production.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19254952_170|19254952|28938|RESULTS|0:0|C-F, siRNA-transfected and serumstarved VSMCs were stimulated  by 100 nm ANG or 10 mum SII for the indicated times  and cell lysates were analyzed for phosphorylated ERK (p-ERK) and  total ERK (ERK).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19254952_244|19254952|41245|DISCUSSION|0:0|However, ERK activation at later time points in VSMCs was not  completely abolished as was previously observed in AT1R-transfected HEK 293  cells, possibly due to incomplete depletion of beta-arrestin2 (~70%) in  primary cultured VSMCs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19254952_90|19254952|13829|RESULTS|0:0|Intracellular Calcium Mobilization and Its Effect on DNA Synthesis and  ERK Activation Stimulated with ANG or SII:ANG regulates vascular  tone and induces mitogenic responses.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19254952_112|19254952|16904|RESULTS|0:0|B-D, serum-starved cells were treated with 100 nm  ANG for the indicated times and cell lysates were analyzed for phosphorylated  ERK (p-ERK) and total ERK (ERK).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19254952_99|19254952|14964|RESULTS|0:0|Pretreatment with PD98059 ablated virtually all activation over basal levels  (n = 5; p < 0.05), indicating that ERK activation  regulates DNA synthesis in VSMCs (Fig. 1B).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19254952_156|19254952|27178|RESULTS|0:0|To answer this question, we examined ERK activation after  ANG and SII stimulation in the presence of various pharmacological inhibitors  of components thought to be involved in the EGFR transactivation pathway.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19254952_194|19254952|32195|RESULTS|0:0|These levels are similar to those obtained with the EGFR kinase  inhibitor, shown in Fig. 6, A and  E. These data demonstrate that both ANG- and  SII-stimulated ERK activation require Src kinase activity.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19254952_197|19254952|33417|RESULTS|0:0|EGFR-dependent activation of ERK mediated by ANG and SII  stimulation.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19254952_239|19254952|41245|DISCUSSION|0:0|On the other hand, ANG-  and SII-induced ERK activation in VSMCs peaks at 5 min and is quite transient,  decreasing to background levels by 30 min.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19254952_2|19254952|18287|#section_info|0:0|In contrast, depletion of beta-arrestin2 leads to  decreased ERK activation (by over 30%) at the later time points |#main_body|GO:0070374|positive regulation of ERK1 and ERK2 cascade|#go_definition|IMP|GOA|Arrb2(25388)|#gene_synonym
0.68	19254952_243|19254952|41245|DISCUSSION|0:0|Furthermore, depletion of beta-arrestin2, but not of beta-arrestin1, using  RNAi leads to inhibition of ANG-mediated ERK activation at later time points  in VSMCs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19254952_244|19254952|41245|DISCUSSION|0:0|However, ERK activation at later time points in VSMCs was not  completely abolished as was previously observed in AT1R-transfected HEK 293  cells, possibly due to incomplete depletion of beta-arrestin2 (~70%) in  primary cultured VSMCs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19254952_159|19254952|27178|RESULTS|0:0|Next, we investigated the contribution of EGFR kinase  activity particularly for the beta-arrestin2-dependent pathway by testing  ANG-mediated ERK activation in the presence of AG1478 after depletion of  beta-arrestin2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19254952_246|19254952|43209|DISCUSSION|0:0|In the case of 7TM  receptor-mediated ERK activation, the later phase of beta-arrestin-dependent  ERK activation is sometimes blocked by depletion of either beta-arrestin, by  depletion of beta-arrestin2, but not beta-arrestin1, or vice versa  depending on receptor and cell type.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19254952_249|19254952|43209|DISCUSSION|0:0|In the present study, ANG-mediated ERK activation in  beta-arrestin1 siRNA-transfected VSMCs was not enhanced compared with that  from control siRNA-transfected cells except at the 2-min time point, and  SII-mediated ERK activation was not changed in beta-arrestin1  siRNA-transfected cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19254952_130|19254952|20090|RESULTS|0:0|In contrast, pretreatment with PKC inhibitors (15 mum GFX and 10  mum Go6983) resulted in dramatic decreases (~75%) in ERK  activation at early time points (1 and 2 min) after ANG stimulation, but  little inhibition was observed at longer time points (10 and 20 min)  (Fig. 4).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19254952_8|19254952|220|abstract|0:0|ERK activation at early  time points but not later time points is strongly inhibited by those protein  kinase C inhibitors that can block protein kinase Czeta.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19254952_242|19254952|41245|DISCUSSION|0:0|In VSMCs, pretreatment  with PKC inhibitors also specifically inhibits early activation of ERK  (1-2 min) but not that at later time points, indicating that early  activation of ERK requires G-protein-mediated second messenger production.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19254952_158|19254952|27178|RESULTS|0:0|In the presence of AG1478, an EGFR-specific kinase inhibitor,  ANG-induced ERK activation is dramatically inhibited at all tested time points  (Fig. 6, A and  B).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19254952_179|19254952|30556|RESULTS|0:0|In addition, SII-mediated ERK activation was virtually completely abolished  by AG1478 as shown in Fig. 6, E  and F. Because SII only activates  beta-arrestin-dependent pathways, this is clear evidence that EGFR kinase  activity is required for beta-arrestin2-dependent ERK activation in VSMCs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19254952_3|19254952|19396|#section_info|0:0|SII-stimulated ERK activation is completely lost in beta-arrestin2  siRNA-transfected VSMCs|#main_body|GO:0070374|positive regulation of ERK1 and ERK2 cascade|#go_definition|IMP|GOA|Arrb2(25388)|#gene_synonym
0.61	19254952_160|19254952|27178|RESULTS|0:0|6, C and  D. ANG-stimulated ERK activation was inhibited by AG1478  in both control and beta-arrestin2 siRNA-transfected VSMCs (reduced to  ~40-50% of maximal ANG stimulation  (Fig. 6, B and  D).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19254952_4|19254952|19396|#section_info|0:0|ANG- and  SII-induced DNA synthesis was significantly inhibited only by deletion of  beta-arrestin2 (Fig.  3C). |#main_body|GO:2000573|positive regulation of DNA biosynthetic process|#go_definition|IMP|GOA|Arrb2(25388)|#gene_synonym
0.77	19254952_186|19254952|31128|RESULTS|0:0|Furthermore, we observed that both  ANG- and SII-induced DNA synthesis were significantly inhibited by  pretreatment with AG1478 (Fig. 6I).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19254952_98|19254952|14964|RESULTS|0:0|1A), it  significantly increased DNA synthesis (thymidine incorporation) to a level  similar to that provoked by ANG or EGF stimulation in VSMCs  (Fig. 1B).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19254952_5|19254952|22642|#section_info|0:0|, at least partially, mediates ANG-induced early  ERK activation,|#main_body|GO:0070374|positive regulation of ERK1 and ERK2 cascade|#go_definition|IMP|GOA|Prkcz(25522)|#gene_synonym
0.62	19254952_242|19254952|41245|DISCUSSION|0:0|In VSMCs, pretreatment  with PKC inhibitors also specifically inhibits early activation of ERK  (1-2 min) but not that at later time points, indicating that early  activation of ERK requires G-protein-mediated second messenger production.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19254952_6|19254952|22642|#section_info|0:0|ANG-induced ERK activation at early time points  (<5 min) was significantly decreased in cells transfected with PKCzeta  siRNA compared with that in control siRNA-transfected VSMCs  |#main_body|GO:0070374|positive regulation of ERK1 and ERK2 cascade|#go_definition|IMP|GOA|Prkcz(25522)|#gene_synonym
0.78	19254952_249|19254952|43209|DISCUSSION|0:0|In the present study, ANG-mediated ERK activation in  beta-arrestin1 siRNA-transfected VSMCs was not enhanced compared with that  from control siRNA-transfected cells except at the 2-min time point, and  SII-mediated ERK activation was not changed in beta-arrestin1  siRNA-transfected cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.72	19254952_177|19254952|28938|RESULTS|0:0|F, SII-induced ERK activation was not  significantly different between PKCzeta siRNAs and CTL siRNA-transfected  VSMCs.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	19254952_244|19254952|41245|DISCUSSION|0:0|However, ERK activation at later time points in VSMCs was not  completely abolished as was previously observed in AT1R-transfected HEK 293  cells, possibly due to incomplete depletion of beta-arrestin2 (~70%) in  primary cultured VSMCs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	19254952_255|19254952|45689|DISCUSSION|0:0|Moreover, it has been  observed that AT1R-mediated ERK activation requires EGFR kinase activity in  several cell types including C9 hepatocytes and COS-7 cells transfected with  the AT1R as well as in VSMCs  (19,  39).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	19254952_119|19254952|16904|RESULTS|0:0|The siRNA transfected condition  shows significant differences compared with control siRNA-transfected cells at  each time point (*, p < 0.05; **, p < 0.01).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19254952_164|19254952|28938|RESULTS|0:0|VSMCs were transfected with control (CTL) siRNA or siGENOME ON-TARGET  plus a set of four rat PKCzeta siRNAs (Dharmacon) using Lipofectamine 2000.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19254952_198|19254952|33417|RESULTS|0:0|A-F, VSMCs were transfected with control  (CTL) or beta-arrestin2 siRNAs using Lipofectamine 2000.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19254952_237|19254952|41245|DISCUSSION|0:0|AT1R-mediated ERK activation in  VSMCs is more transient than that in AT1R-transfected HEK 293 cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	19254952_138|19254952|22642|RESULTS|0:0|To further validate the role of PKCzeta in  beta-arrestin-dependent (or G protein-dependent) pathways, we also  stimulated VSMCs transfected with PKCzeta siRNA with SII.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19254952_130|19254952|20090|RESULTS|0:0|In contrast, pretreatment with PKC inhibitors (15 mum GFX and 10  mum Go6983) resulted in dramatic decreases (~75%) in ERK  activation at early time points (1 and 2 min) after ANG stimulation, but  little inhibition was observed at longer time points (10 and 20 min)  (Fig. 4).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19254952_170|19254952|28938|RESULTS|0:0|C-F, siRNA-transfected and serumstarved VSMCs were stimulated  by 100 nm ANG or 10 mum SII for the indicated times  and cell lysates were analyzed for phosphorylated ERK (p-ERK) and  total ERK (ERK).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19254952_175|19254952|28938|RESULTS|0:0|Signal at each  point is expressed as percentage of the maximal p-ERK signal-stimulated ANG  for 5 min in CTL siRNA VSMCs.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19254952_253|19254952|44875|DISCUSSION|0:0|We  showed that inhibition of PKCzeta activity using chemical inhibitors or by  depletion of its expression by RNAi inhibited G protein-dependent (early time  point) AT1R-mediated ERK activation in VSMCs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19254952_165|19254952|28938|RESULTS|0:0|A, representative Western blot for expression of PKCzeta and actin  after siRNA transfection was shown.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19254952_166|19254952|28938|RESULTS|0:0|B, the expression levels of  PKCzeta after siRNA transfection were measured by Western blot and  normalized with its loading control (actin).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19254952_242|19254952|41245|DISCUSSION|0:0|In VSMCs, pretreatment  with PKC inhibitors also specifically inhibits early activation of ERK  (1-2 min) but not that at later time points, indicating that early  activation of ERK requires G-protein-mediated second messenger production.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19254952_108|19254952|16904|RESULTS|0:0|VSMCs were transfected with the control (CTL),  beta-arrestin1 and -2 siRNAs using Lipofectamine 2000.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19254952_132|19254952|20090|RESULTS|0:0|The  kinetic pattern of ERK activation in the presence of the PKC inhibitors GFX  and Go6983 in VSMCs (Fig. 4) is similar to that observed previously for ANG-stimulated,  beta-arrestin2-dependent ERK activation in HEK 293 cells expressing AT1R  (13).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19254952_153|19254952|27178|RESULTS|0:0|ANG- and SII-mediated ERK Activation Is Dependent on EGFR Kinase and  Metalloprotease 2/9 in VSMCs:It is known that AT1R-mediated EGFR  transactivation plays an important role in proliferation of various cell types  including VSMCs (19).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19254952_235|19254952|41245|DISCUSSION|0:0|Here, we studied  ANG-stimulated ERK activation in a physiologically relevant cell type, rat  VSMCs, and compared the results to those observed previously in HEK 293 cells  transiently transfected with AT1R.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19254952_109|19254952|16904|RESULTS|0:0|A,  representative Western blot for expression of beta-arrestins after siRNA  transfection was shown.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19254952_112|19254952|16904|RESULTS|0:0|B-D, serum-starved cells were treated with 100 nm  ANG for the indicated times and cell lysates were analyzed for phosphorylated  ERK (p-ERK) and total ERK (ERK).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19254952_113|19254952|16904|RESULTS|0:0|B, representative  Western blot for ANG induced p-ERK and ERK in siRNA-transfected VSMCs was  shown.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19254952_190|19254952|32195|RESULTS|0:0|Dominant negative mutants  of c-Src lead to decreases in ANG-induced ERK activation in VSMCs  (23).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19254952_243|19254952|41245|DISCUSSION|0:0|Furthermore, depletion of beta-arrestin2, but not of beta-arrestin1, using  RNAi leads to inhibition of ANG-mediated ERK activation at later time points  in VSMCs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19254952_63|19254952|10621|EXPERIMENTAL PROCEDURES|0:0|For Western blotting for ERK activation, VSMCs on 6-well plates were  starved for at least 48 h in serum-free medium prior to stimulation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19254952_7|19254952|22642|#section_info|0:0|ANG-induced ERK activation at early time points  (<5 min) was significantly decreased in cells transfected with PKCzeta  siRNA compared with that in control siRNA-transfected VSMCs  |#main_body|GO:0070374|positive regulation of ERK1 and ERK2 cascade|#go_definition|IMP|GOA|Prkcz(25522)|#gene_synonym
0.78	19254952_249|19254952|43209|DISCUSSION|0:0|In the present study, ANG-mediated ERK activation in  beta-arrestin1 siRNA-transfected VSMCs was not enhanced compared with that  from control siRNA-transfected cells except at the 2-min time point, and  SII-mediated ERK activation was not changed in beta-arrestin1  siRNA-transfected cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.72	19254952_177|19254952|28938|RESULTS|0:0|F, SII-induced ERK activation was not  significantly different between PKCzeta siRNAs and CTL siRNA-transfected  VSMCs.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	19254952_244|19254952|41245|DISCUSSION|0:0|However, ERK activation at later time points in VSMCs was not  completely abolished as was previously observed in AT1R-transfected HEK 293  cells, possibly due to incomplete depletion of beta-arrestin2 (~70%) in  primary cultured VSMCs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	19254952_255|19254952|45689|DISCUSSION|0:0|Moreover, it has been  observed that AT1R-mediated ERK activation requires EGFR kinase activity in  several cell types including C9 hepatocytes and COS-7 cells transfected with  the AT1R as well as in VSMCs  (19,  39).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	19254952_119|19254952|16904|RESULTS|0:0|The siRNA transfected condition  shows significant differences compared with control siRNA-transfected cells at  each time point (*, p < 0.05; **, p < 0.01).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19254952_164|19254952|28938|RESULTS|0:0|VSMCs were transfected with control (CTL) siRNA or siGENOME ON-TARGET  plus a set of four rat PKCzeta siRNAs (Dharmacon) using Lipofectamine 2000.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19254952_198|19254952|33417|RESULTS|0:0|A-F, VSMCs were transfected with control  (CTL) or beta-arrestin2 siRNAs using Lipofectamine 2000.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19254952_237|19254952|41245|DISCUSSION|0:0|AT1R-mediated ERK activation in  VSMCs is more transient than that in AT1R-transfected HEK 293 cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	19254952_138|19254952|22642|RESULTS|0:0|To further validate the role of PKCzeta in  beta-arrestin-dependent (or G protein-dependent) pathways, we also  stimulated VSMCs transfected with PKCzeta siRNA with SII.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19254952_130|19254952|20090|RESULTS|0:0|In contrast, pretreatment with PKC inhibitors (15 mum GFX and 10  mum Go6983) resulted in dramatic decreases (~75%) in ERK  activation at early time points (1 and 2 min) after ANG stimulation, but  little inhibition was observed at longer time points (10 and 20 min)  (Fig. 4).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19254952_170|19254952|28938|RESULTS|0:0|C-F, siRNA-transfected and serumstarved VSMCs were stimulated  by 100 nm ANG or 10 mum SII for the indicated times  and cell lysates were analyzed for phosphorylated ERK (p-ERK) and  total ERK (ERK).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19254952_175|19254952|28938|RESULTS|0:0|Signal at each  point is expressed as percentage of the maximal p-ERK signal-stimulated ANG  for 5 min in CTL siRNA VSMCs.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19254952_253|19254952|44875|DISCUSSION|0:0|We  showed that inhibition of PKCzeta activity using chemical inhibitors or by  depletion of its expression by RNAi inhibited G protein-dependent (early time  point) AT1R-mediated ERK activation in VSMCs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19254952_165|19254952|28938|RESULTS|0:0|A, representative Western blot for expression of PKCzeta and actin  after siRNA transfection was shown.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19254952_166|19254952|28938|RESULTS|0:0|B, the expression levels of  PKCzeta after siRNA transfection were measured by Western blot and  normalized with its loading control (actin).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19254952_242|19254952|41245|DISCUSSION|0:0|In VSMCs, pretreatment  with PKC inhibitors also specifically inhibits early activation of ERK  (1-2 min) but not that at later time points, indicating that early  activation of ERK requires G-protein-mediated second messenger production.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19254952_108|19254952|16904|RESULTS|0:0|VSMCs were transfected with the control (CTL),  beta-arrestin1 and -2 siRNAs using Lipofectamine 2000.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19254952_132|19254952|20090|RESULTS|0:0|The  kinetic pattern of ERK activation in the presence of the PKC inhibitors GFX  and Go6983 in VSMCs (Fig. 4) is similar to that observed previously for ANG-stimulated,  beta-arrestin2-dependent ERK activation in HEK 293 cells expressing AT1R  (13).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19254952_153|19254952|27178|RESULTS|0:0|ANG- and SII-mediated ERK Activation Is Dependent on EGFR Kinase and  Metalloprotease 2/9 in VSMCs:It is known that AT1R-mediated EGFR  transactivation plays an important role in proliferation of various cell types  including VSMCs (19).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19254952_235|19254952|41245|DISCUSSION|0:0|Here, we studied  ANG-stimulated ERK activation in a physiologically relevant cell type, rat  VSMCs, and compared the results to those observed previously in HEK 293 cells  transiently transfected with AT1R.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19254952_109|19254952|16904|RESULTS|0:0|A,  representative Western blot for expression of beta-arrestins after siRNA  transfection was shown.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19254952_112|19254952|16904|RESULTS|0:0|B-D, serum-starved cells were treated with 100 nm  ANG for the indicated times and cell lysates were analyzed for phosphorylated  ERK (p-ERK) and total ERK (ERK).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19254952_113|19254952|16904|RESULTS|0:0|B, representative  Western blot for ANG induced p-ERK and ERK in siRNA-transfected VSMCs was  shown.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19254952_190|19254952|32195|RESULTS|0:0|Dominant negative mutants  of c-Src lead to decreases in ANG-induced ERK activation in VSMCs  (23).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19254952_243|19254952|41245|DISCUSSION|0:0|Furthermore, depletion of beta-arrestin2, but not of beta-arrestin1, using  RNAi leads to inhibition of ANG-mediated ERK activation at later time points  in VSMCs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19254952_63|19254952|10621|EXPERIMENTAL PROCEDURES|0:0|For Western blotting for ERK activation, VSMCs on 6-well plates were  starved for at least 48 h in serum-free medium prior to stimulation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19254952_8|19254952|24178|#section_info|0:0|Depletion of beta-arrestin2 shows  significant reduction on both ANG- and SII-mediated thymidine incorporation |#fig_caption|GO:2000573|positive regulation of DNA biosynthetic process|#go_definition|IMP|GOA|Arrb2(25388)|#gene_synonym
0.62	19254952_122|19254952|19396|RESULTS|0:0|To further validate the contribution of  beta-arrestin2 to VSMC proliferation, we measured ANG- and SII-induced  thymidine incorporation as an indicator of DNA synthesis and cell  proliferation in VSMCs after depletion of beta-arrestin1 or -2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19254952_9|19254952|36487|#section_info|0:0|Both ANG- and SII-induced EGFR phosphorylation at Tyr-845  is dramatically reduced by depletion of beta-arrestin2 expression by siRNA.|#main_body|GO:0001934|positive regulation of protein phosphorylation|#go_definition|NONE|GOA|Arrb2(25388)|#gene_synonym
0.72	19254952_259|19254952|45689|DISCUSSION|0:0|We also found that  stimulation with either ANG or SII induced EGFR phosphorylation at Tyr-845 by  Src kinase, which is known to activate EGFR.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	19254952_10|19254952|220|abstract|0:0|beta-Arrestin2  facilitates ANG and SII stimulation of Src-mediated phosphorylation of Tyr-845  on the EGFR, a known site for Src phosphorylation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19254952_180|19254952|30556|RESULTS|0:0|Our results utilizing RNA interference and pharmacological inhibitors reveal  that beta-arrestin-dependent ERK activation requires EGFR kinase activity,  suggesting that EGFR transactivation is required for both G protein and  beta-arrestin2-dependent ERK activation by AT1R.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19254952_153|19254952|27178|RESULTS|0:0|ANG- and SII-mediated ERK Activation Is Dependent on EGFR Kinase and  Metalloprotease 2/9 in VSMCs:It is known that AT1R-mediated EGFR  transactivation plays an important role in proliferation of various cell types  including VSMCs (19).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19254952_159|19254952|27178|RESULTS|0:0|Next, we investigated the contribution of EGFR kinase  activity particularly for the beta-arrestin2-dependent pathway by testing  ANG-mediated ERK activation in the presence of AG1478 after depletion of  beta-arrestin2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19254952_316|19254952|48817|DISCUSSION|0:0|The abbreviations used are: 7TM, seven transmembrane; AT1R, angiotensin  type 1 receptor; ANG, angiotensin II; SII,  [Sar1,Ile4,Ile8]-angiotensin II; ERK,  extracellular signal-regulated kinase; PKC, protein kinase C; siRNA, small  interfering RNA; HEK, human embryonic kidney; VSMC, vascular smooth muscle  cell; EGFR, epidermal growth factor receptor; GRK, G protein-coupled receptor  kinases; BiPS,  2R-[(4-biphenylsulfonyl)amino]-N-hydroxy-3-phenylpropinamide;  MEK, mitogen-activated protein kinase/extracellular signal-regulated kinase  kinase; RNAi, RNA interference; GFX, bisindolylmaleimide I; ANOVA, analysis of  variance.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19254952_163|19254952|28938|RESULTS|0:0|Effects of PKCzeta RNAi on AT1R-mediated phosphorylation of ERK.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19254952_241|19254952|41245|DISCUSSION|0:0|By utilizing  beta-arrestin RNAi and PKC inhibitors, two pathways for ERK activation by  the AT1R expressed in HEK 293 cells have been distinguished previously; rapid  and transient G protein-dependent activation, which is sensitive to PKC  inhibitors versus slow and prolonged beta-arrestin2-dependent  activation, which is sensitive to beta-arrestin2 RNAi  (13).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19254952_255|19254952|45689|DISCUSSION|0:0|Moreover, it has been  observed that AT1R-mediated ERK activation requires EGFR kinase activity in  several cell types including C9 hepatocytes and COS-7 cells transfected with  the AT1R as well as in VSMCs  (19,  39).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19254952_107|19254952|16904|RESULTS|0:0|Effects of beta-arrestin RNAi on ANG-mediated phosphorylation of  ERK.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19254952_170|19254952|28938|RESULTS|0:0|C-F, siRNA-transfected and serumstarved VSMCs were stimulated  by 100 nm ANG or 10 mum SII for the indicated times  and cell lysates were analyzed for phosphorylated ERK (p-ERK) and  total ERK (ERK).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19254952_253|19254952|44875|DISCUSSION|0:0|We  showed that inhibition of PKCzeta activity using chemical inhibitors or by  depletion of its expression by RNAi inhibited G protein-dependent (early time  point) AT1R-mediated ERK activation in VSMCs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19254952_10|19254952|37959|#section_info|0:0|Depletion of beta-arrestin2 shows a significant  reduction on both ANG and SII mediated phosphorylation of EGFR at Tyr-845  compared with its own agonist stimulation in the control siRNA-transfected  condition (**, p < 0.05).|#fig_caption|GO:0001934|positive regulation of protein phosphorylation|#go_definition|IMP|GOA|Arrb2(25388)|#gene_synonym
0.71	19254952_10|19254952|220|abstract|0:0|beta-Arrestin2  facilitates ANG and SII stimulation of Src-mediated phosphorylation of Tyr-845  on the EGFR, a known site for Src phosphorylation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19254952_259|19254952|45689|DISCUSSION|0:0|We also found that  stimulation with either ANG or SII induced EGFR phosphorylation at Tyr-845 by  Src kinase, which is known to activate EGFR.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19254952_197|19254952|33417|RESULTS|0:0|EGFR-dependent activation of ERK mediated by ANG and SII  stimulation.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19254952_156|19254952|27178|RESULTS|0:0|To answer this question, we examined ERK activation after  ANG and SII stimulation in the presence of various pharmacological inhibitors  of components thought to be involved in the EGFR transactivation pathway.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19254952_87|19254952|11914|EXPERIMENTAL PROCEDURES|0:0|p-ERK activation was expressed as percentage of the maximal  phosphorylated ERK obtained by ANG stimulation at 5 min.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19254952_249|19254952|43209|DISCUSSION|0:0|In the present study, ANG-mediated ERK activation in  beta-arrestin1 siRNA-transfected VSMCs was not enhanced compared with that  from control siRNA-transfected cells except at the 2-min time point, and  SII-mediated ERK activation was not changed in beta-arrestin1  siRNA-transfected cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19254952_159|19254952|27178|RESULTS|0:0|Next, we investigated the contribution of EGFR kinase  activity particularly for the beta-arrestin2-dependent pathway by testing  ANG-mediated ERK activation in the presence of AG1478 after depletion of  beta-arrestin2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19254952_194|19254952|32195|RESULTS|0:0|These levels are similar to those obtained with the EGFR kinase  inhibitor, shown in Fig. 6, A and  E. These data demonstrate that both ANG- and  SII-stimulated ERK activation require Src kinase activity.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
